BLLN - BillionToOne • Financials

BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year	Revenue	EBITDA	Net Inc	Net Mrg	EPS	Equity	ROE	Net Debt Aj	ND/EBITDA Aj	OCF Aj	Capex	FCF	Free Aj	Buyback	Payout	DY
12/2023	72	-64	-	L	L	-219	L	-62	-	-59	-6	13	-65	0	-	-
12/2024	153	-40	-	L	L	-252	L	-140	-	-50	-5	141	-55	-1	-	-
12/2025	305	23	-	1%	0.17	480	0.7%	-439	-	9	-9	289	-0	0	-	-

To see all financials—including updated, you must be Premium.